Jefferies analyst Owen Bennett maintained a Hold rating on Aurora Cannabis (ACB – Research Report) on January 1 and set a price target of C$0.61. The company’s shares closed yesterday at $0.47.
Bennett covers the Healthcare sector, focusing on stocks such as OrganiGram Holdings, Aurora Cannabis, and Cronos Group. According to TipRanks, Bennett has an average return of -12.6% and a 33.02% success rate on recommended stocks.
Currently, the analyst consensus on Aurora Cannabis is a Hold with an average price target of $0.65.
See today’s best-performing stocks on TipRanks >>
The company has a one-year high of $1.21 and a one-year low of $0.41. Currently, Aurora Cannabis has an average volume of 7.54M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Aurora Cannabis (ACB) Company Description:
Aurora Cannabis, Inc. engages in the production, distribution and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.
Read More on ACB:
- Rising High: Exclusive talk with REIT Healing Realty Trust
- Rising High: Exclusive talk with biotech company Tryp Therapeutics
- Rising High: Exclusive talk with cannabis REIT NewLake Capital
- Here’s What You Missed in Cannabis, Psychedelics This Week
- Republican Rep. to introduce cannabis legalization bill, Forbes says
